{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT12345678",
      "briefTitle": "Phase 2 Study of Test Drug in Breast Cancer",
      "officialTitle": "A Phase 2 Study of Test Drug in Patients with Breast Cancer"
    },
    "statusModule": {
      "overallStatus": "Recruiting"
    },
    "designModule": {
      "phases": ["Phase 2"]
    },
    "conditionsModule": {
      "conditions": [
        {
          "name": "Breast Cancer",
          "code": "254837009",
          "codeSystem": "http://snomed.info/sct"
        },
        {
          "name": "HER2 Positive Breast Cancer",
          "code": "427685000",
          "codeSystem": "http://snomed.info/sct"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n- Age >= 18 years\n- Histologically confirmed breast cancer\n- HER2 positive disease\n- ECOG performance status 0-1\n\nExclusion Criteria:\n- Prior chemotherapy for metastatic disease\n- Brain metastases\n- Active infection",
      "minimumAge": "18 Years",
      "maximumAge": "No upper limit",
      "sex": "All",
      "healthyVolunteers": false
    },
    "armsInterventionsModule": {
      "interventions": [
        {
          "type": "Drug",
          "name": "Test Drug",
          "description": "Experimental targeted therapy"
        }
      ]
    },
    "locationsModule": {
      "locations": [
        {
          "facility": "Test Hospital",
          "city": "Test City",
          "state": "Test State",
          "country": "United States"
        }
      ]
    }
  }
}